Personalized medicine, one goal of molecular diagnostics that is already being clinically realized, offers the opportunity to treat individuals on a case-by-case basis with greater efficacy and efficiency than ever before.
Molecular diagnostics is heading the way of personalized medicine, aiming to help physicians devise particular treatment plans for individuals based on their genetic makeup.
“This is a very exciting time. We’re seeing this incredible focus on molecular diagnostics from the medical community and also from the investment community,” says Paul Beresford, vice president of Business Development and Strategic Marketing for Biodesix, Broomfield, Colo, a fully integrated molecular diagnostics company developing products that support excellence in clinical decision-making and improve patient care